1.4B (+5.5% Y/Y), organic +7.1%; reported diluted EPS $2.12 (-4.9% Y/Y) on non-cash equity-security fair-value hit, adjusted diluted EPS $2.36 (+5.4% Y/Y; +5.8% ex-FX); smoke-free >40% of Q3 revenue; IQOS HTU shipments 41.5B (+1.5%); US ZYN shipments 3.2B pouches (+4.2%); FY26 adj EPS guide tightened to $8.29–$8.44 (+9.9%–11.9%); PM -~1.6% intraday to ~96.73" /> 1.4B (+5.5% Y/Y), organic +7.1%; reported diluted EPS $2.12 (-4.9% Y/Y) on non-cash equity-security fair-value hit, adjusted diluted EPS $2.36 (+5.4% Y/Y; +5.8% ex-FX); smoke-free >40% of Q3 revenue; IQOS HTU shipments 41.5B (+1.5%); US ZYN shipments 3.2B pouches (+4.2%); FY26 adj EPS guide tightened to $8.29–$8.44 (+9.9%–11.9%); PM -~1.6% intraday to ~96.73" />